Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreatic adenocarcinoma

Show simple item record

dc.contributor University of Helsinki, Research Programs Unit en
dc.contributor University of Helsinki, CAN-PRO - Translational Cancer Medicine Program en
dc.contributor.author Grbovic-Huezo, Olivera
dc.contributor.author Pitter, Kenneth
dc.contributor.author Lecomte, Nicolas
dc.contributor.author Saglimbeni, Joseph
dc.contributor.author Askan, Gokce
dc.contributor.author Holm, Matilda
dc.contributor.author Melchor, Jerry
dc.contributor.author Chandwani, Rohit
dc.contributor.author Joshi, Suhasini
dc.contributor.author Haglund, Caj
dc.contributor.author Iacobuzio-Donahue, Christine
dc.contributor.author Chiosis, Gabriela
dc.contributor.author Tammela, Tuomas
dc.contributor.author Leach, Steven
dc.date.accessioned 2021-01-13T04:49:02Z
dc.date.available 2021-01-13T04:49:02Z
dc.date.issued 2020-11-16
dc.identifier.citation Grbovic-Huezo , O , Pitter , K , Lecomte , N , Saglimbeni , J , Askan , G , Holm , M , Melchor , J , Chandwani , R , Joshi , S , Haglund , C , Iacobuzio-Donahue , C , Chiosis , G , Tammela , T & Leach , S 2020 , ' Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreatic adenocarcinoma ' , Proceedings of the National Academy of Sciences of the United States of America , vol. 117 , no. 48 , pp. 30670-30678 . https://doi.org/10.1073/pnas.1920240117 en
dc.identifier.issn 0027-8424
dc.identifier.other PURE: 151386464
dc.identifier.other PURE UUID: 1ff83e82-3c76-4c9d-a6ef-df4238409533
dc.identifier.other WOS: 000596476100016
dc.identifier.other ORCID: /0000-0001-8453-3936/work/86940700
dc.identifier.uri http://hdl.handle.net/10138/324442
dc.format.extent 9
dc.language.iso eng
dc.relation.ispartof Proceedings of the National Academy of Sciences of the United States of America
dc.rights en
dc.subject 3122 Cancers en
dc.subject pancreatic cancer en
dc.subject PDAC en
dc.subject HSP90 en
dc.subject trametinib en
dc.subject MEK en
dc.subject 3111 Biomedicine en
dc.title Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreatic adenocarcinoma en
dc.type Article
dc.description.version Peer reviewed
dc.identifier.doi https://doi.org/10.1073/pnas.1920240117
dc.type.uri info:eu-repo/semantics/other
dc.type.uri info:eu-repo/semantics/publishedVersion
dc.contributor.pbl
dc.contributor.pbl
dc.contributor.pbl

Files in this item

Total number of downloads: Loading...

Files Size Format View
30670.full.pdf 2.071Mb PDF View/Open

This item appears in the following Collection(s)

Show simple item record